Trial
NCT07049432
N-803 Maintenance Therapy Post CAR T-cell Therapy in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphomas
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Utah
Collaborators
ImmunityBio, Inc.
Condition
B-cell Non Hodgkin Lymphoma
Intervention
N803
Why stopped
Drug Unavailable
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-01